Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- Google's healthcare team is reorganizing;
- Doctors and drugmakers disagree on when we might need coronavirus booster shots;
- What a lawsuit against Centene reveals about pharmaceutical middlemen.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…
Just a heads up that there will be no newsletter tomorrow, in observance of Juneteenth. I'll be back in your inbox first thing Monday.

Dr. David Feinberg, head of Google Health, talks to a crowd during his tenure as CEO of Geisinger Health in 2015.
Lisa Lake/Getty Images

Lisa Lake/Getty Images
EXCLUSIVE: Google is downsizing its health team and moving employees to Fitbit as part of a major reorganization
- Google's young health division is splintering, according to employees and an email seen by Insider.
- Google Health teams working on sensors, search, and health records are moving to Fitbit and Search.
- It's yet another growing pain for a big tech company that's still finding its voice in healthcare.

Marianne Ayala/Insider
One year or 5? Doctors and drug companies increasingly disagree about when we'll need COVID-19 booster shots

- Booster shots may not be medically necessary for another one to five years, disease experts wager.
- But pharmaceutical companies are prepping to distribute boosters to the US before the end of 2021.
- In either case, boosters probably won't require the same urgency as initial vaccines do.

Centene CEO Michael Neidorff.
Steven Ferdman/Getty Images

Steven Ferdman/Getty Images
A lawsuit against the largest provider of government health insurance gives a rare glimpse into how pharmacy benefit managers can make money
- Centene just settled litigation over the practices of its pharmacy benefit managers, or PBMs.
- As part of the $88 million settlement in Ohio, the Ohio attorney general's complaint was unsealed.
- The complaint offers a rare glimpse at how some PBMs make money.
More stories we're reading:
- CureVac's COVID-19 shot just failed in a large trial, a major setback for the Gates-backed biotech (Insider)
- Digital health companies are outgrowing highly specific markets. One expert says that's fueling the consolidation wave overtaking the industry. (Insider)
- Inside Apple's health ambitions, which have struggled to take off (The Wall Street Journal)
- Bernie Sanders tells us he's 'delighted' Ron DeSantis cribbed his idea to import prescription drugs from Canada (Insider)
- Mississippi is suing three drugmakers over insulin prices (Endpoints News)
- Lydia
Read the original article on Business Insider